In the latest development to the referral regarding whether post-published evidence can be used to prove the existence of a technical effect, the Enlarged Board of Appeal have scheduled the G 2/21 hearing for 24 November 2022. We will be reporting on the result as soon as it is available. In the meantime, read our primers on the background to the referral and likely consequences of the decision.
Related resources
Does T 116/18 Tip the Balance in Favour of Patentees in the Post-Published Evidence Debate at the EPO?
The Enlarged Board of Appeal in G 2/21 established new requirements for determining when post‑published evidence can be...
G 1/22 and G 2/22: EPO Publishes Decision on Priority Entitlement
The EPO have published the eagerly anticipated G1/22 and G2/22 decision of the Enlarged Board of Appeal, providing...
Patent Law & Practice at a Glance
We regularly review changes to patent law and practice at the UKIPO, EPO and in other jurisdictions so...
T 873/21 – A Stable Decision or More Plausibility Fences to Jump?
The Enlarged Board of Appeal in G 2/21 established new guidance for determining when post‑published evidence can be...
Patent Law & Practice at a Glance
We regularly review changes to patent law and practice at the UKIPO, EPO and in other jurisdictions so...
GJE Leads on IP Support on Pivlaz® (Clazosentan) And Daridorexant Due Diligence as Part of Sosei Group Corporation Acquisition of Idorsia’s Pharmaceuticals Business in Japan and APAC (Ex-China)
On 20 July 2023, Sosei Group Corporation, which oversees GJE client and leading fully integrated biopharmaceutical company Heptares...